Contribution of BMP9 to Pulmonary Arterial Hypertension

A. Sekine (Le Plessis-Robinson, France)

Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Session: New perspectives from experimental models of pulmonary hypertension
Session type: Oral Presentation
Number: 4658
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sekine (Le Plessis-Robinson, France). Contribution of BMP9 to Pulmonary Arterial Hypertension. 4658

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of CHK1 in Pulmonary Arterial Hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018



Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Pulmonary Hypertension
Source: Eur Respir Rev 2009; 18: 193-194
Year: 2009


Pulmonary Hypertension
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013


Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

CT Based Arterial and Venous Morphologic Changes In Pulmonary Hypertension Associated with COPD
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Cerebral tissue oxygenation in arterial and thromboembolic pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Cerebral oxygenation in highlanders with high altitude pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014

Supraventricular Arrhythmias in Pulmonary Arterial Hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017